16377-62-1 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 6-fluoro-4-oxo-1,4-dihydroquinoline-2-carboxylate is used as a potential pharmaceutical agent for its structural similarity to the anti-malarial drug chloroquine. Its potential applications may include the development of new drugs for the treatment of malaria or other diseases, given its unique molecular structure and properties.
Used in Drug Formulation:
Ethyl 6-fluoro-4-oxo-1,4-dihydroquinoline-2-carboxylate is used as a component in drug formulations due to its enhanced solubility in organic solvents, which can improve the bioavailability and efficacy of the drug. The ethyl ester group in the compound contributes to its increased solubility, making it a valuable candidate for the development of new drug formulations.
Used in Medicinal Chemistry Research:
Ethyl 6-fluoro-4-oxo-1,4-dihydroquinoline-2-carboxylate is used as a research compound in medicinal chemistry to explore its potential biological activities and properties. The presence of the fluorine atom in the molecule may provide unique characteristics that can be harnessed for the development of new therapeutic agents. Further research is needed to fully understand the compound's potential and its effects on various biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 16377-62-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,3,7 and 7 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 16377-62:
(7*1)+(6*6)+(5*3)+(4*7)+(3*7)+(2*6)+(1*2)=121
121 % 10 = 1
So 16377-62-1 is a valid CAS Registry Number.
16377-62-1Relevant academic research and scientific papers
Facile synthesis of 4-quinolone derivatives via one-pot cascade reaction under transition-metal-free conditions
Huang, Chao,Guo, Jia-Hui,Fu, Huang-Mei,Yuan, Ming-Long,Yang, Li-Juan
supporting information, p. 3777 - 3781 (2015/06/08)
A practical and efficient strategy has been described for the preparation of 4-quinolone derivatives. Using commercially available diethyl acetylenedicarboxylate and aromatic amines as starting materials, the synthetic protocol has been achieved and affor
